OpenVSafe by OpenVAERS
Search V-safe

6DG-29424-20193

2 vaccinations 4 coded responses 14 check-ins 4 free-text entries 1 call case
Sex
Female
Age at first dose
21-25
ZIP prefix
151 / PA
Registered
2020-12-23
Relationship
Self

Timeline

  1. 2020-12-23
    Registered in v-safe
  2. 2020-12-23
    Dose 1 — Pfizer-BioNTech
  3. 2020-12-23
    Health check-in — day 0, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2020-12-27
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Headache
    Adult check-in
  5. 2020-12-28
    Survey response — days 1–6 daily, dose 1
    MedDRA: Decreased appetite, Lacrimation increased, Somnolence — Feeling: Fair · Headache, Fatigue or tiredness, Diarrhea · Be unable to work
    Free text: Right eye waters by it self, loss of appetite, very very sleepy.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2020-12-28
  7. 2020-12-29
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Swelling · Headache, Diarrhea
    Adult check-in
  8. 2020-12-30
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-01-06
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  10. 2021-01-15
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-01-18
    Dose 2 — Pfizer-BioNTech
  12. 2021-01-19
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Swelling · Chills, Headache, Fatigue or tiredness, Nausea, Abdominal pain
    Adult check-in
  13. 2021-01-20
    Survey response — day 0, dose 2
    MedDRA: Urticaria — Feeling: Poor · Site: Swelling, Itching · Chills, Headache, Fatigue or tiredness, Nausea, Abdominal pain
    Free text: Hives
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-01-20
    Survey response — days 1–6 daily, dose 2
    MedDRA: Urticaria — Feeling: Fair · Site: Redness, Swelling, Itching · Headache, Fatigue or tiredness, Nausea
    Free text: Hives
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-01-21
    Survey response — days 1–6 daily, dose 2
    MedDRA: Urticaria — Feeling: Good · Site: Redness, Swelling · Joint pains, Fatigue or tiredness, Nausea, Diarrhea
    Free text: Hives
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-01-22
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain, Swelling · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  17. 2021-01-27
    Health check-in — day 7, dose 2
    Feeling: Poor · Headache, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  18. 2021-02-08
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12020-12-23Pfizer-BioNTech
22021-01-18Pfizer-BioNTech

Call center

ReportedOutcomeVAERS-related outcome
2020-12-28 priority 2/3

Free text

Release 1 — days 1–6 daily, dose 1

2020-12-28

Systemic reaction (other): Right eye waters by it self, loss of appetite, very very sleepy.

Release 2 — day 0, dose 2

2021-01-20

Systemic reaction (other): Hives

Release 2 — days 1–6 daily, dose 2

2021-01-20

Systemic reaction (other): Hives

2021-01-21

Systemic reaction (other): Hives

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SRODecreased appetite ✓ ✓ ✓
SROLacrimation increased ✓ ✓ ✓
SROSomnolence ✓ ✓ ✓
SROUrticaria ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release